Reduction and carbamidomethylation of the intrachain disulfide bridges of human growth hormone did not destroy its ability to stimulate weight gain or cartilage metabolism in hypophysectomized rats. The reduced and alkylated hormone also stimulated glucose oxidation in isolated adipose tissue of hypophysectomized rats when added in vitro. When the S-carbamidomethylated hormone was incubated overnight with human plasmin, approximately 95% of the starting material was completely digested, as judged by polyacrylamide gel electrophoresis. The plasmin digest retained the ability to stimulate weight gain, cartilage metabolism, and glucose oxidation. A fraction consisting of two major electrophoretic components was isolated from the digest by chromatography on Sephadex G-50. This fraction possessed the biological properties of the whole digest.
Plasmin digests of human growth hormone (hGH) retain the biological properties of the native hormone in the rat and man (1) (2) (3) (4) . The active component of the digests has been isolated and shown to consist of amino-acid residues 1-134 attached to residues 141-191 by the disulfide bond between residues 53 and 165 (3, 4) . Reduction and S-carbamidomethylation of this large fragment produces two peptides, one consisting of residues 1-134 (peptide 2a) and the other comprising residues 141-191 (peptide 2(). Peptide 2a exhibits a high degree of biological activity in vitro but appears to be quite labile when injected subcutaneously or intraperitoneally into the rat. It must be injected intravenously in order to obtain the full expression of its biological activity in the whole animal (1, 3) . Peptide 2(3 appears to be biologically inactive.
Since these studies suggested that the biological activity of growth hormone resides in the amino-acid sequence comprising peptide 2a, it was of interest to explore alternative and more efficient means to produce substantial amounts of this peptide for further fragmentation studies. As indicated above, the primary action of plasmin on native hGH is the cleavage of two peptide bonds resulting in the removal of the hexapeptide consisting of residues 135-140. The possibility was considered that plasmin might have the same mode of attack on reduced and S-carbamidomethylated hGH (RCAM-hGH) resulting in the production of peptide 2a directly. Thus in the present study, hGH was first reduced and S-carbamidomethylated and then digested with human plasmin. The biological properties of such digests are described below.
MATERIALS AND METHODS
Human growth hormone was dissolved in 1.4 M Tris HCl buffer at pH 8.6 and brought to a concentration of 10 mg/ml.
Reduction of its disulfide bonds was accomplished by the addition of solid dithiothreitol to give a 5-fold molar excess over protein disulfide. This solution was allowed to stand at room temperature for 30 min, and then solid iodoacetamide was added to give a 4.8-fold molar excess over dithiothreitol.
The solution was then allowed to stand in the dark for 15 min, after which it was dialyzed against distilled water and lyophilized. The degree of reduction and alkylation was assessed by amino-acid analysis of the product and found to be complete.
Digestion of the S-carbamidomethylated hormone with human plasmin (KABI, Stockholm, Sweden) and fractionation of the digestion products by gel filtration were carried out as previously described for native hGH (2, 3) .
Materials prepared as described above were assayed for biological activity in three test systems. The 9-day weight gain test (5) (2) . Results are expressed in terms of dpm of 14CO2 produced/mg of wet tissue per hr.
RESULTS
Reduction and S-carbamidomethylation of hiGH did not markedly alter the growth-promoting activity of the hormone. (Table 3) .
When various preparations of RCAM-hGH were incubated overnight at 370 with human plasmin, approximately 95% of the starting material was completely digested, as indicated by the greater mobility of the bulk of the material when subjected to disc gel electrophoresis (6) . The disc gel pattern of a typical digest is compared to that of the starting material in Table 1 . This activity cannot be due to the small amount of undigested RCAM-hGH present in the preparations. The results shown in Tables 2 and 3 also indicate that the digests of RCAM-hGH retained the ability to stimulate thymidine uptake into cartilage and to stimulate in vitro glucose oxidation by isolated adipose tissue. Again, the degree of activity is such that the effects obtained cannot be attributed to the residual amount of undigested RCAM-hGH remaining in the preparations.
In order to separate the major components of the plasmin digests of RCAM-hGH from small cleavage products, ly- ophilized digests were dissolved in 1 M propionic acid and subjected to gel filtration on Sephadex G-50 fine in 0.01 N HCl. A typical elution pattern is shown in Fig. 2 . Five absorbance peaks were identified and designated peaks R1 to R5. Peak R1 appeared to be a mixture of aggregated digestion products and undigested precursor. Peak R2 contained the major digestion products, as indicated by disc gel electrophoresis of the material (Fig. 1B) . Peaks R3 to R5 contained a mixture of small peptides. Only one of these has been identified, namely, the hexapeptide consisting of residues 135-140, which eluted in peak R5. It will be recalled that this is the peptide that is cleaved from native hGH when it is digested with plasmin.
The biological properties of native hGH are retained by the material present in peak R2. The results given in Tables 1 RCAM- hGH has metabolic activity in man. Further, plasmin digests of RCAM-hGH retain the ability to stimulate weight gain, cartilage metabolism, and glucose oxidation. These biological properties are present in the major peptide components of the digests, namely, those isolated in chromatographic fraction R2.
It is of particular interest that the plasmin digests of RCAM-hGH have a high degree of activity in the weight gain and cartilage metabolism tests, in which the test substances are injected subcutaneously and intraperitoneally, respectively. As indicated earlier, peptide 2a (residues 1-134) only exhibited substantial activity in the whole animal when administered intravenously, suggesting that it is quite labile in vivo. If RCAM-hGH is hydrolyzed by plasmin in the same manner that hGH is, namely, that the peptide bonds between residues 134 and 135 and between residues 140 and 141 are cleaved, one might expect that the digests of RCAM-hGH would have the in vivo lability characteristic of peptide 2a. Since the digests of RCAM-hGH do contain hexapeptide 135-140, the action of plasmin on RCAM-hGH is in fact similar to its action on native hGH. However, digestion of RCAM-hGH may be more extensive, perhaps yielding a fragment of the hormone more stable in vivo than peptide 2a. Alternatively, the somewhat simpler chemical manipulations involved in the production of the digests of RCAM-hGH might account for the preservation of high in vivo biological activity. In 
